The Pennant Group, Inc.
NASDAQ:PNTGMedical - Care Facilities
-$0.83 today
- Market cap
- $1.26B
- Beta
- 1.27
- P/E (TTM)
- 38.6
- EPS (TTM)
- $0.87
Volume 0.43M
Average 0.25M
PNTG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The Pennant Group, Inc.NASDAQ: PNTG
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How PNTG compares with its peers on the latest reported figures
- PNTG's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for PNTG, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PNTG) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 439.69M | 473.24M | 544.89M | 695.24M | 947.71M |
| Cost of Revenue | 391.1M | 414.66M | 477.86M | 601.48M | 825.24M |
| Gross Profit | 48.6M | 58.59M | 67.04M | 93.76M | 122.47M |
| Gross Margin | 11.1% | 12.4% | 12.3% | 13.5% | 12.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 36.26M | 33.98M | 36.67M | 50.21M | 71.08M |
| Operating Expenses | 43.9M | 45.85M | 41.87M | 55.65M | 71.08M |
| Depreciation & Amortization | 4.78M | 4.9M | 5.13M | 6.12M | 8.54M |
| EBITDA | 9.46M | 17.61M | 30.64M | 44.44M | 60.85M |
| EBITDA Margin | 2.2% | 3.7% | 5.6% | 6.4% | 6.4% |
| Operating Income | 4.7M | 12.74M | 25.17M | 38.12M | 51.39M |
| Operating Margin | 1.1% | 2.7% | 4.6% | 5.5% | 5.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.94M | 3.82M | 5.92M | 6.96M | 6.68M |
| Other Income / Expenses | (1.97M) | (3.85M) | (5.59M) | (6.75M) | (5.76M) |
| Income Before Tax | 2.73M | 8.89M | 19.58M | 31.37M | 45.63M |
| Pre-Tax Margin | 0.6% | 1.9% | 3.6% | 4.5% | 4.8% |
| Income Tax Expense | 582K | 1.65M | 5.67M | 7.03M | 11.87M |
| Net Income | 2.7M | 6.64M | 13.38M | 22.56M | 29.58M |
| Net Margin | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% |
| EPS (Basic) | 0.08 | 0.23 | 0.45 | 0.72 | 0.86 |
| EPS (Diluted) | 0.07 | 0.22 | 0.44 | 0.71 | 0.84 |
| Weighted Avg Shares | 28.41M | 29.06M | 29.86M | 31.19M | 34.56M |
| Weighted Avg Shares (Diluted) | 30.64M | 30.16M | 30.19M | 32M | 35.32M |
The Pennant Group, Inc.
NASDAQ:PNTG
Intrinsic Alpha fair value
Locked
Current Price
$35.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.